Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D3.
Adjunctive vitamin D treatment for pulmonary tuberculosis enhances resolution of inflammation but has modest effects on bacterial clearance. Sodium 4-phenylbutyrate (PBA) is in clinical use for a range of conditions and has been shown to synergise with vitamin D metabolites to upregulate cathelicidi...
Main Authors: | Anna K Coussens, Robert J Wilkinson, Adrian R Martineau |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-07-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC4489717?pdf=render |
Similar Items
-
Extraction, Bacteriostatic Effect and Synergistic Mechanism of Bacteriostatic Effect of Taxifolin in Larch in Combination with Leucocyanidin
by: Licheng JING, et al.
Published: (2024-01-01) -
Saposin D acting on macrophage bacteriostatic function in experimental tuberculosis infection
by: G. S. Shepelkova, et al.
Published: (2021-06-01) -
Metabolism of 25-Hydroxy-Vitamin D in Human Macrophages Is Highly Dependent on Macrophage Polarization
by: Rie H. Nygaard, et al.
Published: (2022-09-01) -
Phenylbutyrate facilitates homeostasis of non-resolving inflammatory macrophages
by: Allison Rahtes, et al.
Published: (2020-01-01) -
Bacteriostatic cells instead of bacteriostatic antibiotics?
by: Fernando Baquero, et al.
Published: (2024-02-01)